A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

NCT00788489 · clinicaltrials.gov ↗
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ontario Clinical Oncology Group (OCOG)

Collaborators